Also known as: Aclidinium bromide

Therapeutic indications

Aclidinium is indicated for:

Chronic obstructive pulmonary disease (COPD)

Population group: both men and women, only adults (18 - 65 years old)

Aclidinium is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines